Breast Imaging: Page 41

Breast MRI underutilized in high-risk women
By Kate Madden Yee
Supplemental screening breast MRI is underused by women at higher risk of breast cancer, according to a study published in the June issue of the Journal of Women's Health.
June 19, 2018
2016 10 05 17 45 45 493 Breast Cancer 400
Synthesized 2D mammo works well for density assessment
By Kate Madden Yee
Breast density assessments rendered by radiologists from synthesized 2D digital breast tomosynthesis exams are comparable to those rendered from standard 2D mammography images, according to a study published online June 12 in the Journal of the American College of Radiology.
June 13, 2018
2016 11 15 14 47 22 735 Breast Dbt 400
Mo. passes breast tomosynthesis coverage bill
By AuntMinnie.com staff writers
Before his May 29 resignation, Missouri Gov. Eric Greitens signed a bill into law that requires the state's insurers to provide benefits and coverage for both 2D mammography and 3D digital breast tomosynthesis, according to the American College of Radiology.
June 11, 2018
Breast MRI improves PPV for BI-RADS category 4B lesions
By AuntMinnie.com staff writers
Breast MRI improves the positive predictive value (PPV) of BI-RADS category 4B (moderate suspicion of malignancy) for mammographic microcalcifications, according to a study published online May 28 in Clinical Radiology.
June 5, 2018
DBT plus DM finds 90% more cancer than mammo alone
By Kate Madden Yee
The combination of digital mammography (DM) plus digital breast tomosynthesis (DBT) finds 90% more breast cancer than digital mammography alone -- and with a similar recall rate, according to a study published online June 5 in Radiology.
June 5, 2018
2016 08 18 13 26 22 430 Breast Screening Mammo 400
DBT improves diagnostic mammography, too
By Kate Madden Yee
It's not just for screening anymore: A new study found that using digital breast tomosynthesis (DBT) in the diagnostic setting reveals more cancers and produces fewer false positives than 2D digital mammography.
May 17, 2018
2016 11 15 14 47 22 735 Breast Dbt 400
ARRS: Added radiation exposure from DBT is within limits
By Wayne Forrest
WASHINGTON, DC - While digital breast tomosynthesis (DBT) increases radiation exposure for women when used with digital mammography for screening, the combined dose remains well within safety standards, according to a study presented on Monday at the American Roentgen Ray Society (ARRS) meeting.
April 23, 2018
2016 10 18 11 34 57 70 Check Mark 400
ABUS reads are short enough for busy clinical practices
By AuntMinnie.com staff writers
Busy radiologists can rest assured that automated breast ultrasound (ABUS) interpretation times won't gum up the workflow in their practices, according to a study published April 13 in Academic Radiology.
April 18, 2018
How can unnecessary ABUS recalls be avoided?
By Kate Madden Yee
Automated breast ultrasound (ABUS) can yield lower recall rates than handheld ultrasound, but unnecessary recalls still occur -- and it's important to find ways to reduce them, according to research presented at the recent American Institute of Ultrasound in Medicine annual meeting in New York City.
April 15, 2018
2016 09 06 13 31 23 491 Question Mark Blue 400
DBT improves breast cancer screening in young women
By Kate Madden Yee
Adding digital breast tomosynthesis (DBT) to digital mammography improves breast cancer screening in women younger than 50, decreasing recalls and finding more cancers in those who have dense tissue, according to a study published online April 9 in the American Journal of Roentgenology.
April 12, 2018
2016 08 26 11 32 34 470 Breast Mammo 400
FDA authorizes ACR to accredit DBT devices
By AuntMinnie.com staff writers
The American College of Radiology (ACR) has received authorization from the U.S. Food and Drug Administration (FDA) to manage the accreditation process for FDA-approved digital breast tomosynthesis (DBT) units, effective April 9.
April 4, 2018
Is screening breast MRI being used in the wrong women?
By Kate Madden Yee
More than 80% of screening breast MRI exams are performed on women for whom the test is not necessarily recommended -- that is, women with a lifetime risk for the disease of less than 20%, according to a study published in the March issue of the Journal of General Internal Medicine.
March 29, 2018
2016 09 06 13 31 23 491 Question Mark Blue 400
Previous Page
Page 41 of 89
Next Page